Pharma 2020 has activated Russian biomanufacturing tech market says GE Healthcare
Government efforts to encourage local drug production have “activated” the Russian biomanufacturing technology market according to GE Healthcare.
Government efforts to encourage local drug production have “activated” the Russian biomanufacturing technology market according to GE Healthcare.
WuXi has responded to a global demand for perfusion technologies by opening a commercial scale manufacturing site in China with two 1,000L disposable bioreactors.